UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Professor Keith Andrew Wesnes (1950 to 2020)

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2020, Vol.12 (1), p.e12086-n/a

2020

Volltextzugriff (PDF)

Building clinically relevant outcomes across the Alzheimer's disease spectrum

Alzheimer's & dementia : translational research & clinical interventions, 2021, Vol.7 (1), p.e12181-n/a

2021

Volltextzugriff (PDF)

A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced Difficulty

Frontiers in digital health, 2021-11, Vol.3, p.780303-780303

2021

Volltextzugriff (PDF)

US depiction of the appendix: role of abdominal wall thickness and appendiceal location

Emergency radiology, 2011-12, Vol.18 (6), p.525-531

2011

Volltextzugriff (PDF)

Cognitive Go/No-Go decision-making criteria in Alzheimer’s disease drug development

Drug discovery today, 2021-05, Vol.26 (5), p.1330-1336

2021

Volltextzugriff (PDF)

Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials

Alzheimer's & dementia, 2023-02, Vol.19 (2), p.696-707

2023

Volltextzugriff (PDF)

Recommendations on the Selection, Development, and Modification of Performance Outcome Assessments: A Good Practices Report of an ISPOR Task Force

Value in health, 2023-07, Vol.26 (7), p.959-967

2023

Volltextzugriff (PDF)

Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2

Journal of Alzheimer's disease, 2021-01, Vol.83 (2), p.915-925

2021

Volltextzugriff (PDF)

Use of Qualitative Data to Support Content Validity of Performance-Based Cognitive Outcome Assessments

Therapeutic innovation & regulatory science, 2017-11, Vol.51 (6), p.671-671

Edgar, Chris J.

2017

Volltextzugriff (PDF)

The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial

Journal of psychopharmacology (Oxford), 2016-06, Vol.30 (6), p.559-567

2016

Volltextzugriff (PDF)

The role of human cognitive neuroscience in drug discovery for the dementias

Current opinion in pharmacology, 2014-02, Vol.14, p.62-73

2014

Volltextzugriff (PDF)

Effects of nicotine withdrawal on cognition in a clinical trial setting

Psychopharmacology, 2013-09, Vol.229 (1), p.133-140

2013

Volltextzugriff (PDF)

Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptoms

Psychiatry research, 2014-08, Vol.218 (1), p.219-224

2014

Volltextzugriff (PDF)

Defining therapeutic benefit for people with schizophrenia: Focus on negative symptoms

Schizophrenia research, 2015-03, Vol.162 (1), p.169-174

2015

Volltextzugriff (PDF)

Adaptation and Modification of Digital Cognitive Assessments for Smartphone‐based and Unsupervised Conduct

Alzheimer's & dementia, 2023-12, Vol.19 (S21), p.n/a

Edgar, Chris J.

2023

Volltextzugriff (PDF)

FREE AND CUED SELECTIVE REMINDING TEST AS AN INCLUSION CRITERION FOR EARLY ALZHEIMER'S DISEASE CLINICAL TRIAL POPULATIONS

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P343-P344

2016

Volltextzugriff (PDF)

PSYCHOMETRIC VALIDATION OF A NOVEL SCORING ALGORITHM FOR THE ZARIT CAREGIVER INTERVIEW FOR ALZHEIMER’S DISEASE (ZCI-AD)

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P300-P300

2016

Volltextzugriff (PDF)

Psychometric evaluation of the Work Readiness Questionnaire in schizophrenia

CNS spectrums, 2016-04, Vol.21 (2), p.199-206

2016

Volltextzugriff (PDF)

Validity and utility of the PANSS negative symptoms factor score as a clinical trial outcome

Schizophrenia research, 2014, Vol.158 (1), p.e4-e4

2014

Volltextzugriff (PDF)

ESTABLISHING EQUIVALENCE OF ELECTRONIC CLINICIAN-REPORTED OUTCOME MEASURES

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P565-P565

2016

Volltextzugriff (PDF)

THE PREDICTIVE UTILITY OF COGNITIVE MEASURES AT SCREENING FOR DETERMINATION OF CSF ABETA (1-42) STATUS IN SUBJECTS WITH PRODROMAL ALZHEIMER'S DISEASE: DATA FROM THE SCARLET ROAD TRIAL

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P821-P822

2016

Volltextzugriff (PDF)

Clinical Manifestations

Alzheimer's & dementia, 2023-12, Vol.19 Suppl 18, p.e077060

2023

Volltextzugriff (PDF)

Sensitivity of individual and composite test scores from the Cogstate Brief Battery to mild cognitive impairment and dementia due to Alzheimer’s disease

Alzheimer's & dementia, 2023-12, Vol.19 (S18), p.n/a

2023

Volltextzugriff (PDF)

Equating the ADAS‐Cog and MMSE to Cogstate Brief Battery scores

Alzheimer's & dementia, 2023-12, Vol.19 (S18), p.n/a

2023

Volltextzugriff (PDF)

Detection of Mild Cognitive Impairment Using In‐clinic and Remote Unsupervised Digital Cognitive Assessments

Alzheimer's & dementia, 2022-12, Vol.18 (S7), p.n/a

2022

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(169)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(182)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(116)
Life Sciences & Biomedicine
(94)
Humans
(70)
Male
(42)
Female
(35)
Middle Aged
(30)
Aged
(23)
Adult
(20)
Animals
(15)
Patients
(14)
Biological And Medical Sciences
(13)
Clinical Trials
(12)
Neurosciences & Neurology
(12)
Medicine
(11)
Medicine & Public Health
(11)
Multidisciplinary Sciences
(11)
Oncology
(11)
Physical Sciences
(11)
Psychiatry
(11)
Science & Technology - Other Topics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Professor Keith Andrew Wesnes (1950 to 2020)

Building clinically relevant outcomes across the Alzheimer's disease spectrum

A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced Difficulty

US depiction of the appendix: role of abdominal wall thickness and appendiceal location

Cognitive Go/No-Go decision-making criteria in Alzheimer’s disease drug development

Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials

Recommendations on the Selection, Development, and Modification of Performance Outcome Assessments: A Good Practices Report of an ISPOR Task Force

Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2

Use of Qualitative Data to Support Content Validity of Performance-Based Cognitive Outcome Assessments

The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial

The role of human cognitive neuroscience in drug discovery for the dementias

Effects of nicotine withdrawal on cognition in a clinical trial setting

Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptoms

Defining therapeutic benefit for people with schizophrenia: Focus on negative symptoms

Adaptation and Modification of Digital Cognitive Assessments for Smartphone‐based and Unsupervised Conduct

FREE AND CUED SELECTIVE REMINDING TEST AS AN INCLUSION CRITERION FOR EARLY ALZHEIMER'S DISEASE CLINICAL TRIAL POPULATIONS

PSYCHOMETRIC VALIDATION OF A NOVEL SCORING ALGORITHM FOR THE ZARIT CAREGIVER INTERVIEW FOR ALZHEIMER’S DISEASE (ZCI-AD)

Psychometric evaluation of the Work Readiness Questionnaire in schizophrenia

Validity and utility of the PANSS negative symptoms factor score as a clinical trial outcome

ESTABLISHING EQUIVALENCE OF ELECTRONIC CLINICIAN-REPORTED OUTCOME MEASURES

THE PREDICTIVE UTILITY OF COGNITIVE MEASURES AT SCREENING FOR DETERMINATION OF CSF ABETA (1-42) STATUS IN SUBJECTS WITH PRODROMAL ALZHEIMER'S DISEASE: DATA FROM THE SCARLET ROAD TRIAL

Clinical Manifestations

Sensitivity of individual and composite test scores from the Cogstate Brief Battery to mild cognitive impairment and dementia due to Alzheimer’s disease

Equating the ADAS‐Cog and MMSE to Cogstate Brief Battery scores

Detection of Mild Cognitive Impairment Using In‐clinic and Remote Unsupervised Digital Cognitive Assessments

Suchergebnisse filtern